Rapid multiplex PCR on bronchoalveolar lavage to guide antibiotics for ventilator-associated pneumonia
Official title: Fast Multiplex PCR of Bronchoalveolar Lavage for Antibiotic Stewardship in Ventilator Associated Pneumonia. A Multicenter, Randomized Controlled Study
Run by CHU de Reims · NCT06554327 · Data updated 2026-11-12
This trial tests whether using a fast multiplex PCR on bronchoalveolar lavage samples helps doctors choose the right antibiotics sooner for adults on mechanical ventilation suspected of ventilator-associated pneumonia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 265 (estimated) |
| Sponsor | CHU de Reims Academic / other |
| Locations | 1 site (Reims) |
| Status | Recruiting |
| Started | March 6, 2025 |
| Main results expected | September 6, 2030 |
| Study ends | October 4, 2030 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT06554327 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult ICU patients on mechanical ventilation for at least 48 hours with suspected VAP who have an indication for bronchoalveolar lavage and meet consent and coverage requirements.
✕Probably not a fit
Patients who will not have bronchoalveolar lavage, those intubated less than 48 hours, those with a prior VAP during the same hospital stay, pregnant patients, or patients under legal protection/no social security are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, randomized controlled trial in eight university intensive care units in the Grand-Est region of France comparing multiplex PCR plus standard bacterial culture versus bacterial culture alone for suspected VAP. The multiplex test used is the BioFire FilmArray Pneumonia Panel Plus, performed on bronchoscopic bronchoalveolar lavage fluid and able to detect multiple bacterial DNA targets and resistance genes. Standard culture and susceptibility results typically take 48–72 hours, while the PCR gives much faster results that could inform empirical antibiotic choices. The primary comparison is the percentage of appropriate empirical antibiotic therapy in patients with culture-confirmed VAP.
Why it matters
Potential benefit: If successful, the approach could let clinicians choose more appropriate antibiotics sooner, reducing unnecessary broad-spectrum use and potentially improving patient outcomes.
How similar studies have gone: Prior work shows multiplex PCR panels detect pathogens and resistance markers faster than culture, but clinical trials have produced mixed results on whether that speed consistently translates into more appropriate antibiotic use or better outcomes in ICUs.
Who can join: the full rules
Show full inclusion / exclusion criteria
inclusion criteria : * Adult patients, hospitalized in intensive care unit * on mechanical ventilation for at least 48 hours * Suspected VAP * With an indication for bronchoalveolar lavage (BAL) exclusion criteria : * Patients under legal protection or without social security coverage * Pregnant women * Previous episode of VAP during the same hospitalization
Where it's running
-
Damien JOLLY
Reims, France Recruiting
Study contacts
- Study coordinator: Antoine GOURY
- Email: agoury@chu-reims.fr
- Phone: 03 10 73 68 85
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Probiotics to Prevent Pneumonia in Critically Ill Kids in the PICU
We’re testing whether giving probiotics to critically ill children on a ventilator helps prevent ventilator-associated pneumonia.
-
B Lymphocyte Populations in the Lungs of ICU Patients on Ventilation
This study tests the presence and roles of B lymphocytes in the lungs of adults on invasive ventilation, to see how humoral immunity relates to ventilator-associated pneumonia.
-
Lactoferrin to help prevent infections in ventilated newborns
This study tests whether giving lactoferrin to ventilated neonates can help prevent ventilator-associated pneumonia and related complications.
-
Measuring breathing effort before and after removing the breathing tube
This will test a new electrical impedance method to measure breathing effort in adults on ventilators as they try breathing on their own and after the breathing tube is removed.
-
Using acyclovir to treat pneumonia in ventilated patients with herpes simplex virus
This study is testing if giving acyclovir to ICU patients on ventilators who have pneumonia and herpes simplex virus can help them survive better than those who don't receive the medication.
-
Standardized oral care using human milk for premature infants in the NICU
This study is trying to see if giving regular oral care using human milk can help very low birth weight babies in the NICU stay healthier and avoid complications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.